NCT07720661

Brief Summary

The COMFORT Trial is a randomized controlled superiority trial comparing skeletonized (SK) versus non-skeletonized (non-SK) harvesting of the left internal mammary artery (LIMA) to left anterior descending artery (LAD) graft in patients undergoing isolated coronary artery bypass grafting (CABG).

Trial Health

45
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Timeline
32mo left

Started Sep 2026

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 17, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

July 22, 2026

Completed
1 month until next milestone

Study Start

First participant enrolled

September 1, 2026

Expected
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2028

4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2029

Last Updated

July 28, 2026

Status Verified

July 1, 2026

Enrollment Period

2.3 years

First QC Date

July 17, 2026

Last Update Submit

July 24, 2026

Conditions

Keywords

CABGLeft Internal Mammary ArterySkeletonized Harvesting

Outcome Measures

Primary Outcomes (1)

  • Number of Participants with Graft Patency

    Binary assessment of LIMA-LAD graft patency versus graft failure

    1.5 years after surgery

Secondary Outcomes (3)

  • MACE

    2 years after surgery

  • Number of Participants with a Sternal Surgical Site Infection

    90 days after surgery

  • Number of Participants with LIMA-LAD Driven Repeat Revascularization or Occlusion

    2 years after surgery

Study Arms (2)

Skeletonized LIMA Harvesting

EXPERIMENTAL

Harvesting of the left internal mammary artery as a skeletonized conduit during CABG surgery, with removal of surrounding tissues while preserving the artery as an isolated graft conduit.

Procedure: Skeletonized LIMA Harvesting

Non-Skeletonized LIMA Harvesting

ACTIVE COMPARATOR

Conventional pedicled harvesting of the left internal mammary artery during CABG surgery, with preservation of the surrounding veins, fascia, and supporting tissues around the graft conduit.

Procedure: Non-Skeletonized LIMA Harvesting

Interventions

Skeletonized (SK) harvesting of the left internal mammary artery (LIMA) to left anterior descending artery (LAD) graft: the LIMA is isolated without surrounding satellite veins, endothoracic fascia, and intercostal nerves

Skeletonized LIMA Harvesting

Non-skeletonized (non-SK) harvesting of the LIMA-LAD graft: the LIMA is harvested with surrounding satellite veins, endothoracic fascia, and intercostal nerves (standard pedicled technique)

Non-Skeletonized LIMA Harvesting

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18 years or older
  • Undergoing isolated CABG surgery with median sternotomy and a planned LIMA-LAD graft
  • Provision of written informed consent

You may not qualify if:

  • Non-sternotomy surgical approach (e.g., minimally invasive, thoracotomy)
  • Emergency surgery (defined as surgery required within 24 hours of presentation)
  • History of prior sternotomy
  • Currently receiving systemic antibiotics or with an active bacterial infection at the time of surgery
  • History of chronic sternal pain prior to the index surgery
  • Known left subclavian artery stenosis (\>50%)
  • Previous radiation therapy to the chest
  • Known allergy or contraindication to iodinated contrast media that cannot be managed with premedication
  • Estimated glomerular filtration rate (eGFR) \<30 mL/min/1.73m² at baseline (relative contraindication to CTA contrast) as determined based on each centre's laboratory standard.
  • Known pregnancy or plans for pregnancy during the study period
  • Life expectancy less than 1.5 years due to non-cardiac conditions
  • Inability or unwillingness to comply with follow-up procedures including CTA at 1.5 years

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Coronary Artery DiseaseSurgical Wound Infection

Condition Hierarchy (Ancestors)

Coronary DiseaseMyocardial IschemiaHeart DiseasesCardiovascular DiseasesArteriosclerosisArterial Occlusive DiseasesVascular DiseasesWound InfectionInfectionsPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Andre Lamy, MD

    Population Health Research Institute

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Participants, data collectors, research coordinators, outcome adjudicators, CTA core laboratory readers, and statisticians are blinded to treatment allocation. Only the operating surgeon and operating room staff are aware of the assigned harvesting technique. CTA images are de-identified prior to core laboratory review, and outcome adjudication is performed by blinded independent committees.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants will be randomized to undergo either skeletonized or non-skeletonized LIMA harvesting during CABG surgery and followed prospectively for comparison of graft patency, clinical outcomes, wound complications, pain, and quality of life between the two parallel treatment groups.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 17, 2026

First Posted

July 22, 2026

Study Start (Estimated)

September 1, 2026

Primary Completion (Estimated)

December 31, 2028

Study Completion (Estimated)

April 30, 2029

Last Updated

July 28, 2026

Record last verified: 2026-07